Home India Ministry of Health and Family Welfare Parliament Question: Use of Molecular Iodine...
Date: 2025-08-08 Category: Not Applicable State: Union Government Country: India

Parliament Question: Use of Molecular Iodine

Issued by Ministry of Health and Family Welfare · Not Applicable

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

This document summarizes the Indian Ministry of Health and Family Welfare's response to a parliamentary question regarding the use of molecular iodine for disease prevention, including coronavirus infections. As of August 8, 2025, the government possesses data on povidone-iodine, a well-established antiseptic with microbicidal properties effective against previous beta coronaviruses. Scientific literature suggests potential benefits of povidone-iodine mouth rinses and nasal sprays in managing SARS-CoV-2, but these studies are limited by methodological weaknesses, specifically inadequate randomization and small sample sizes. The Ministry acknowledges the risks associated with excessive systemic iodine intake, including thyroid dysfunction, mucosal irritation, metallic taste, and hypersensitivity reactions. Iodine antiseptics, like povidone-iodine, mitigate these risks through controlled topical application and appropriate dilution. Other established uses of iodine include thyroid gland protection against radioactive iodine, preoperative skin antisepsis, broad-spectrum antimicrobial action, and disinfection of water sources. The Central Drugs Standard Control Organization (CDSCO) reports that no applications for the import, manufacture, marketing, or clinical trials of molecular iodine for disease prevention, including coronavirus infections, have been received. Therefore, the government has not issued specific guidelines or approvals related to molecular iodine through agencies like CDSCO or the Indian Council of Medical Research (ICMR).

Key Entities Referenced

Ministry of Health and Family Welfare: The Indian government ministry responsible for health policy in India. Lok Sabha: The lower house of the Parliament of India, where the question was raised. Molecular Iodine: The substance that is the subject of the question, regarding its use in disease prevention. Coronavirus Infections: A class of viral infections, specifically mentioned in the context of molecular iodine's potential use. SARS-CoV-2: The virus that causes COVID-19, mentioned in the context of povidone-iodine's potential use. Povidone Iodine: An antiseptic with microbicidal properties, used as a comparison to molecular iodine. Central Drugs Standard Control Organization (CDSCO): The national regulatory body for pharmaceuticals and medical devices in India. ICMR: Likely refers to the Indian Council of Medical Research, the apex body in India for the formulation, coordination and promotion of biomedical research.
Official Source Record View Original Source →
See Full Document Text
GOVERNMENTOFINDIA MINISTRYOFHEALTH AND FAMILYWELFARE DEPARTMENTOFHEALTH RESEARCH LOK SABHA UNSTARREDQUESTION NO. 3444 TOBE ANSWERED ON08TH AUGUST,2025 USEOFMOLECULAR IODINE 3444. DR. D RAVIKUMAR: Willthe Ministerof HEALTHANDFAMILYWELFAREbe pleasedtostate: (a) whether the Government has any data on the use of molecular iodine for prevention of diseases, includingcoronavirusinfections, inthe countryandglobally; (b) if so, the details of research, development and trials conducted in the country on molecular iodine andevidenceregardingits efficacyinpreventionor treatment of diseases; (c) whether any side effects, contraindications, or safety concerns have been identified in its use as per clinicalor regulatory findingsandif so, the detailsthereof; (d) the steps taken/proposed to be taken by the Government to regulate the production, marketing, and use of moleculariodine in the country; and (e) whether any guidelines or approvals have been issued/proposed by agencies such as CDSCO or ICMR andif so, the detailsthereof? ANSWER THE MINISTER OFSTATE INTHE MINISTRYOFHEALTH ANDFAMILYWELFARE (SHRIPRATAPRAOJADHAV) (a)to(e): Povidone Iodine has been a gold standard antiseptic for decades having microbicidal properties with proven efficacy against the previously identified beta corona-viruses. As per the review of scientific literature, few studies indicate the benefits of using povidone-iodine based mouth rinses and nasal sprays in SARS-CoV-2 management. However, these studies also show inadequate randomization methods and smaller samples. Broader iodine toxicology warns that excessive systemic iodine intake may disrupt thyroid function and cause mucosal irritation, metallic taste, and hypersensitivity reactions. Iodine antiseptics mitigate these risks by limiting systematic exposure through controlled topical application and appropriate dilution. Other uses of Iodine include protection of thyroid gland from the effect of radiation from radioactive form of Iodine, preoperative skin antisepsis as Povidone-Iodine, broad spectrum of antimicrobial action against bacteria, fungi, protozoa and several viruses, and use in disinfecting drinking water, swimming pool water andwaste water. It has been informed by Central Drugs Standard Control Organization (CDSCO) that no application has been received for the import /manufacturing and marketing or clinical trials for the molecular iodine for preventionof diseases, includingcoronavirus infections. *****

Continue your research